Automated control of end-tidal sevoflurane in living donor hepatectomy, a prospective, randomized, controlled study
Open Access
- 1 July 2017
- journal article
- Published by Taylor & Francis in Egyptian Journal of Anaesthesia
- Vol. 33 (3) , 233-237
Abstract
Background: Reduction of anesthesia cost has become a necessity, especially in developing countries. Recently, automated control of end-tidal sevoflurane concentration (EtSev) has been proposed as a new technique with both cost-effectiveness and safety profiles. In this study, sevoflurane consumption (primary outcome variable) was evaluated during living donor hepatectomy using automated control of EtSev (EtC) at fresh gas flow (FGF) of 0.5 and 2 L/min compared to manual control (MC) technique at FGF of 2 L/min. Materials and methods: Prospective, randomized, controlled trial including 60 Potential donors scheduled for living donor right hepatectomy. patients were randomized into 3 equal groups (according to target control of sevoflurane), MC group, EtC-2L group, and EtC-0.5L group. In MC group: FGF was set to 2 L/min, inspired concentration of Sevoflurane (FiSev) was set to 1.5–2% in 0.4 fractional inspired oxygen concentration (FiO2), while in EtC-2L group: FGF was set to 2 L/min, EtSev was set to 1–1.5% with end tidal oxygen concentration (EtO2) target of 0.35. In EtC-0.5L group, FGF was set to minimal flow and EtSev target to 1–1.5% and EtO2 target of 0.35. Anesthetic gases consumption (sevoflurane ml, Oxygen L, and air consumption L) per anesthesia hour were recorded at the end of surgery. Other recorded data included intraoperative hemodynamics, the number of user adjustments, and extubation time. Results: Significant reduction in sevoflurane consumption when EtC-0.5L is used (4.2 ± 1.3 ml/h, 12.6 ± 2.6 ml/h, and 15 ± 2.9 ml/h respectively, p. 0.001). Also, a significant decrease in overall numbers of user adjustments between the three groups (8 times for EtC-0.5L group, 7 times in EtC-2L group, 22 times for MC group, p. 0.008) was observed. Conclusion: automated control of EtSev during anesthesia of living donor hepatectomy significantly lowers sevoflurane consumption and decreases required user interventions without deleterious effect on patient safetyKeywords
This publication has 18 references indexed in Scilit:
- Cost efficiency of target-controlled inhalational anesthesiaJournal of Anaesthesiology Clinical Pharmacology, 2014
- Impact of sevoflurane versus isoflurane on coagulation profile in living donor liver transplant recipients: a prospective randomized trialAin-Shams Journal of Anesthesiology, 2014
- Closed-Loop Control of AnesthesiaAnesthesia & Analgesia, 2013
- End-tidal versus manually-controlled low-flow anaesthesiaJournal of Clinical Monitoring and Computing, 2013
- Automated control of end-tidal inhalation anaesthetic concentration using the GE Aisys Carestation™ †British Journal of Anaesthesia, 2013
- Reducing Wastage of Inhalation Anesthetics Using Real-time Decision Support to Notify of Excessive Fresh Gas FlowAnesthesiology, 2013
- Occupational Fatigue: Impact on Anesthesiologist's Health and the Safety of Surgical PatientsRevista Brasileira de Anestesiologia, 2013
- Low dose ketorolac infusion improves postoperative analgesia combined with patient controlled fentanyl analgesia after living donor hepatectomy – Randomized controlled trialEgyptian Journal of Anaesthesia, 2012
- Assessing the clinical or pharmaco‐economical benefit of target controlled desflurane delivery in surgical patients using the Zeus ® anaesthesia machine*Anaesthesia, 2009
- Low-flow anaesthesiaContinuing Education in Anaesthesia Critical Care & Pain, 2008